Selective laser-mediated gene therapy for ocular diseases

选择性激光介导的眼部疾病基因治疗

• 批准号: 376793
• 负责人: Meunier Michel
• 金额: $ 26.91万
• 依托单位: Polytechnique Montral
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-11-01 至 2020-11-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=376793&lang=en
• 关键词: 1101 Human Health; 1102 Biomedical Engineering; 1901 Biomedical Technology; 2006 Biomaterials; Age-Related Macular Degeneration; Corneal Endothelial Dystrophies; Femtosecond Laser; Gene Therapy; Gold Nanoparticles; Laser Transfection

Ocular diseases affecting the cornea (front part of the eye) or the retina (image processing cells in the back of the eye) are leading causes of vision loss and affect millions of individuals worldwide. These diseases are either incurable or only transien

影响角膜（眼睛前部）或视网膜（眼睛后部的图像处理细胞）的眼部疾病是视力丧失的主要原因，影响着全世界数百万人。这些疾病要么无法治愈，要么只是暂时性的